Médico oftalmologista, Doutorado em medicina pela UNIFESP, Chefe da Retina clínica Grupo Fleury, Fellowship Retina Cirúrgica McGill University.

Médico oftalmologista, Especialista em Retina e Vítreo pela Federal University of São Paulo (UNIFESP) e University of Toronto.

Professor Adjunto da University of Miami, Miller School of Medicine, Miami, EUA; Visiting Professor do Departamento de Oftalmologia, Henry C. Witelson Ocular Pathology Laboratory at McGill University, Montreal; Diretor Clínico da Neovista Oftalmologia – Americana – SP.

Oftalmologista e Doutorando pela UNIFESP/EPM com enfoque em inteligência artificial em Retina. Oftalmologista do Instituto da Visão.

MD, PhD, and Uveitis and Medica Retina specialist. Chief Scientific Officer and Head of research at Augenarzt-Praxisgemeischaft Gutblick AG, adjunct professor at the Northwestern University, Chicago/USA, Director of Eyegnos Consulting and Chief Medical Officer at Isarna Therapeutics.

MD, PhD, Professor of Ophthalmology, Vitreoretinal Diseases Unit, Vitreoretinal Surgery, Department of Ophthalmology, Federal University of São Paulo, Brazil, Past-President of Brazilian Vitreoretinal Society (SBRV) 2020-2022, Vice-President of Pan-American Ophthalmological Foundation (PAOF), President-Elected: Pan-American Vitreoretinal Society (SPRV) – 2025-2026.

MD, PhD, Professor of Ophthalmology at Paulista School of Ophthalmology, Federal University of São Paulo, Past President Brazilian and Pan-American Retina Vitreous Societies, Member of Club Jules Gonin, Macula and Retina Societies, Director of São Paulo Ophalmological Center.

MD, PhD, Professor of Ophthalmology, Pathology, Oncology, Medicine, Surgery, Director, The MUHC-McGill University Ocular Pathology & Translational Research Laboratory McGill University, Montreal – Canada, Member, Chair# XLV, Acad Ophthalmologica Internationalis The Thomas Hecht Family Chair in Ophthalmology (1995-2012); Editor-in-Chief, Emeritus, CJO, Professor Programa Pós-graduação Oftalmologia e Ciências Visuais, Universidade Federal de São Paulo.

MD, CBO, Assistant Professor, Faculty of Medicine, Department of Ophtalmology and Vision Sciences, Low Vision Rehabilitation Program, University of Toronto; Staff, Toronto Western Hospital; University Health Network, Ontario.

Doutorado em Oftalmologia FMUSP, Fellow de Retina Clínica e Cirúrgica Moorfields Eye Hospital, Londres, Responsável Departamento de Oftalmologia Hospital da Gamboa.

MD,Setor de Retina do Instituto Brasileiro de Oftalmologia; Fellow em Retina na Cleveland Clinic; Doutor em Oftalmologia pela UNIFESP.

MD, PhD, Ophalmologist at Oyehelseklinikken and Oslo University Hospital, Eye Department, Oslo, Norway.

The first Scandinavia to get started with offering Valeda treatment to patients with dry AMD. She has treated more than 400 patients, since 2020. She is participating in the Eurolight study, an European multicenter study of the visual acuity effects of photobiomodulation, tolerability and safety as well as the impacto n OCT and Fundus autoflorescence images.

MD, PhD, MBA, Senior Professor Ophtalmology Federal University of São Paulo, Brazil, Senior Investigator, Brazilian Council of Research, President of Vision Institute São Paulo, Brazil, Member of Academia Ophtalmologica Internationalis, Brazilian Academy of Sciences and National Academy of Medicina (Brazil) – Former President.

MD, FRCS(C), Professor of Ophtalmology and Vision Sciences, Faculty of Medicine, University of Toronto; Director, Low Vision Rehabilitation Program, Department of Ophtalmology, University of Toronto; Clinician Investigator, The Krembil Research institute, University Health Network, Toronto.